Author:
Vredenborg Astrid D.,Janmohamed Sherief R.,de Laat Peter C. J.,Madern Gerard C.,Oranje Arnold P.
Publisher
Springer International Publishing
Reference62 articles.
1. Arsham AM, Howell JJ, Simon MC. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem. 2003;278:29655–60.
2. Atherton DJ, Moss C. Naevi and other developmental defects. In: Burn T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. Malden: Blackwell Publishing; 2004. p. 104–5. 15.40–15.55; chapter 15.
3. Bauland CG, van Steensel MA, Steijlen PM, Rieu PN, Spauwen PH. The pathogenesis of hemangiomas: a review. Plast Reconstr Surg. 2006;117:29e–35.
4. Bayliss SJ, Berk DR, Van Hare GF, Balzer D, Yamada K, Lueder G, Lanoel A, de la Fuente V, Cordisco MR. Re: propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2010;27:319–20.
5. Bennett ML, Fleischer Jr AB, Chamlin SL, et al. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol. 2001;137:1208–13.